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Abstract
Nitric oxide interactions with iron are the most important biological reactions in which NO participates. Reversible
binding to ferrous haem iron is responsible for the observed activation of guanylate cyclase and inhibition of cytochrome
oxidase. Unlike carbon monoxide or oxygen, NO can also bind reversibly to ferric iron. The latter reaction is responsible for
the inhibition of catalase by NO. NO reacts with the oxygen adduct of ferrous haem proteins (e.g. oxyhaemoglobin) to
generate nitrate and ferric haem; this reaction is responsible for the majority of NO metabolism in the vasculature. NO can
also interact with iron^sulphur enzymes (e.g. aconitase, NADH dehydrogenase). This review describes the underlying
kinetics, thermodynamics, mechanisms and biological role of the interactions of NO with iron species (protein and non-
protein bound). The possible significance of iron reactions with reactive NO metabolites, in particular peroxynitrite and
nitroxyl anion, is also discussed. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The interaction of nitric oxide with metals has
been studied since the early years of this century
[1]. It is unlikely that the chemists of that time would
have imagined that as the millennium approached
there would still be unsolved questions about metal:
NO interactions, nor that these would be addressed
primarily by life scientists, not inorganic chemists.
Nitric oxide can bind to most transition metals [2].
However, its interactions with iron are by far the
most studied transition metal:NO reactions (Fig.
1). The main NO signal transduction pathway so
far elucidated, the activation of guanylate cyclase,
proceeds via direct binding of NO to haem iron [3].
Furthermore, it has been suggested that NO binding
to ferrous haem in cytochrome oxidase [4^7], ferric
haem in catalase [8] and iron or sulphur atoms in
iron^sulphur proteins [9,10] can all occur under
physiological or pathophysiological conditions.
This review will be an overview of the chemical
interaction of nitric oxide with iron in biological sys-
tems, with particular emphasis on the bene¢ts and
disadvantages of the selection of iron proteins as
evolutionary targets for NO action. By the very na-
ture of the ¢eld, the papers cited will be a selection of
those available, chosen to highlight the chemical
points made (‘nitric oxide+iron’ yielding 129 hits in
a search of the Science Citation Index for papers
published in 1997 alone). The reader is directed to
other reviews in this area for more detailed discus-
sion of the chemistry [2,11^15] and spectroscopy
[16,17] of iron reactions with NO. In particular, there
are many relevant chapters, especially with regard to
spectroscopic techniques, in several recent books de-
scribing methodology in nitric oxide research [18^21].
The reactions of NO with iron can be divided de-
pending upon whether they involve mere binding or
binding+metabolism. The redox state of the iron
(ferrous, ferric or ferryl) also dramatically modulates
whether binding is favoured over metabolism, and in
the former case the strength of the iron^NO bond.
2. Binding reactions of NO and iron
2.1. Binding of NO to ferrous iron
NO Fe2HFe2 ÿNO 1
NO binds reversibly to ferrous iron. Table 1 illus-
trates the relative on rates, o¡ rates, and dissociation
constants for this reaction in a selection of biological
and chemical systems. It is instructive to compare
NO binding to that of CO and O2 for a number of
reasons: (1) their size, charge (neutral) and hydro-
phobicity are similar suggesting similar access to cel-
lular iron pools, whether the latter are low-molecu-
lar-weight or protein-bound; (2) O2 (and to a lesser
extent CO) is likely to be present in higher concen-
trations in most in vivo situations than NO and
therefore could theoretically compete for NO binding
sites on ferrous iron; and (3) once bound, the para-
magnetic properties of NO and O2 result in the ad-
dition of unpaired electrons to the system with the
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result that, unlike CO, simple reversible binding is
not always the only interaction observed.
CO, NO and O2 can all bind reversibly to ferrous
iron. In most proteins, oxygen metabolism by ferrous
iron is faster than its dissociation and therefore the
oxygen adduct is not stable. The exception, of
course, is in the oxygen-transport proteins, such as
haemoglobin and myoglobin, which make stable O2
adducts with measurable on and o¡ rates. A general
comparison for the on rates reveals that O2 and NO
have similar rates (in the order 107^108 M31 s31).
CO on rates, however, are considerable lower (al-
ways 6 107 M31 s31). However, the most interesting
comparison is in the o¡ rates. The greater a⁄nity of
NO over CO for ferrous haem is re£ected in both a
faster on rate and a slower o¡ rate; in some cases the
dissociation rate is so slow (6 1035 s31) as to be
technically very di⁄cult to measure. This creates
clear problems for the role of NO as a signalling
molecule. For example, the half-time of guanylate
cyclase deactivation when NO is removed is less
than a minute, which is clearly impossible if NO
dissociates from this enzyme as slowly as from hae-
moglobin or myoglobin. A similar problem exists for
mitochondrial respiration where there is clear evi-
dence that low levels of NO generate the ferrous
cytochrome oxidase^NO complex, yet respiration re-
turns to normal within seconds once NO is removed
from the solution.
As NO binds so tightly to ferrous haem, it has
been suggested that it might be easier to remove
the haem^NO complex from the protein rather
than simply dissociate the NO from the haem. NO
can dissociate the trans ligand from haem iron and,
therefore, has the potential to destabilise haem bind-
ing to the protein. Indeed guanylate cyclase is fre-
quently puri¢ed as an apoprotein (without the haem
cofactor). It has therefore been suggested that NO-
induced haem dissociation may be responsible for
changes in enzyme activity in vivo [11,13]. Although
this seems an intrinsically ine⁄cient mechanism for
short-term regulation of the NO signal, haem disso-
ciation may be important [11] in limiting cGMP syn-
thesis following prolonged exposure to high NO con-
centrations (and may therefore be a contributing
factor in the development of nitroglycerin tolerance).
In fact, recent data demonstrates that haem dissoci-
ation from proteins is unnecessary for fast NO dis-
sociation and that proteins are able to modify the
microenvironment of the iron^nitrosyl bond to
have substantially higher than expected dissociation
rates for NO: 0.05 s31 for guanylate cyclase [30] and
0.13 s31 for cytochrome oxidase [29]. Thus, increased
NO dissociation rates within proteins allow NO to
have a short-term role in increasing cyclic GMP lev-
els or in modulating mitochondrial respiration. The
on rates for NO are ¢xed at about 108 M31 s31 for
most ferrous haem proteins; this suggests, paradoxi-
cally, that NO binds weaker to ferrous iron in its
target molecules than to other haem proteins, e.g.
myoglobin or haemoglobin.
Comparisons of NO binding between haem pro-
teins and low molecular weight non-haem iron com-
plexes are not straightforward as many of the studies
on the latter are carried out at rather acid pH values
(given the problems of maintaining the ferrous iron
in solution at neutral pH). However, Table 1 reveals
that most of these complexes (including some meas-
ured at close to physiological pH) have signi¢cantly
less a⁄nity for NO than haem proteins. In particular
the fast o¡ rates suggest that in vivo NO will not get
Fig. 1. Publications in 1997 describing nitric oxide interactions
with transition metals. An initial search of titles in the Science
Citation Index for 1997 was made. Articles were selected on the
basis that they contained both the words ‘nitric oxide’ and a
transition metal. The abstracts of the articles selected were then
read and only articles describing direct NO/metal interactions
were selected. The total number of such articles was 33. The
distribution between di¡erent transition metals is illustrated in
the pie chart above. In fact, there was little change if the ab-
stract checking procedure was ignored. A similar direct search
using the titles, keywords, and abstract ¢elds also revealed the
preponderance of references on iron (129 out of the 260 articles
selected).
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‘trapped’ in non-protein iron pools. Interestingly,
model haem iron complexes can have very high af-
¢nity for NO [25,27] and this demonstrates that the
polypeptide chain is not required to facilitate NO
binding to haem proteins. Instead, the role of the
protein microenvironment is likely to be to regulate
the strength of binding (and subsequent protein con-
formation and activity changes) to the physiological
requirements.
There is one further important point to make
about NO binding to haem proteins. In stark con-
trast to CO and O2, NO in general binds more
tightly to ferrous iron in the absence of a trans ligand
[13]. In practice, this means that NO binding will
frequently dissociate the trans ligand; alternatively,
the binding of a trans ligand can force NO dissocia-
tion. The former e¡ect has been demonstrated in a
number of proteins by EPR spectroscopy as the 5-
coordinate and 6-coordinate complexes have distinct
spectra [39]. In guanylate cyclase, for example, bind-
ing of NO displaces the proximal histidine ligand and
this may induce conformational changes in the pro-
tein that increase the cyclase activity [3] (as well as
increasing the tendency for haem dissociation de-
scribed above).
Conversely, changing the protein’s structure to
force a ligand to bind trans to the NO (and hence
weaken the Fe2^NO bond) is one possible answer
to the biological necessity of removing NO from fer-
rous haem proteins. NO dissociation from 6-coordi-
nate model haems occurs at least 1000 times faster
than from otherwise similar 5-coordinate haems [25].
The dissociation rate of NO from guanylate cyclase
is increased 100-fold (Table 1) in the presence of
Table 1
A comparison of the kinetic and thermodynamic constants for nitric oxide, carbon monoxide and oxygen binding to ferrous iron in


































5U107 15 3U1037 2U107 1.8U1035 0.9U10312 6.0U106 0.01 1.7U1039 [22]
Haemoglobin
(T-state)
4.5U106 1900 4.2U1034 2U107 3U1033 1.5U10310 8.3U104 0.09 1.1U1036 [22,23]
Myoglobin 1.4U107 10 7.1U1037 1.7U107 1.2U1034 0.7U10311 5.0U105 0.17 3.4U1037 [24,25]
Cytochrome c ^ ^ ^ 8.3U100 2.9U1035 3.5U1036 ^ ^ ^ [26,27]
Cytochrome
oxidase
1U108 ^ ^ 1U108 0.13 1.3U1039 7U104 0.023 3U1037 [28,29]
Guanylate
cyclase




^ ^ ^ 7U108 0.05 0.7U10310 ^ ^ [30,31]
Fe2 (acac)2,
pH 6.6
^ ^ ^ 4U102 24 5.9U1032 ^ ^ ^ [32]
Fe2 citrate,
pH 5.1
^ ^ ^ 4.4U105 6.6U102 1.5U1033 ^ ^ ^ [32]
Fe2 EDTA,
pH 5.1




^ ^ ^ 6.2U105 1.4U103 2U1033 ^ ^ ^ [35]
The references in the table refer to the nitric oxide data. Values for CO and O2 binding taken from references [36^38]. ^, not deter-
mined or not measurable. The pH for the protein studies was in the physiological range (7^7.4). The pH for the inorganic complexes
is indicated in the table. Apart from the case of Fe2 EDTA, the dissociation constant has been determined as the ratio of the o¡
and on rates, rather than being measured directly.
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Mg2 and GTP. GTP has been shown to perturb the
Raman spectrum of the Fe2^NO bond [40] and it
may therefore increase NO dissociation by forcing
the proximal histidine to re-bind to the iron [30].
These di¡erent roles of NO, CO and O2 as ferrous
haem ligands are illustrated in Fig. 2.
2.2. Binding of NO to ferric iron
NO Fe3HFe3 ÿNO Fe2 ÿNO 2
Another distinction between NO binding to iron
and that of CO and O2, is that NO can also bind
reversibly to ferric iron. In contrast to the case with
Fig. 2. (A) Geometry of binding of nitric oxide, oxygen and carbon monoxide to ferrous haem iron. NO and O2 bind in a 130^150‡
angle. CO prefers a linear geometry, but due to the presence of steric hindrance in the distal side of the haem pocket is frequently
forced to bind with a non-preferred bent angle. Thus, as well as the intrinsic weakness of the Fe(II)^CO bond (compared to that of
Fe(II)^NO), steric factors can further contribute to the increased a⁄nity of haem proteins for NO, rather than CO. (B) Possible ef-
fects of NO on trans ligand binding (and vice versa) in ferrous haem nitrosyl complexes. Unlike CO and O2, NO binding decreases
the a⁄nity of a trans ligand and can thus dissociate it, forming a 5-coordinate complex. The displaced ligand (L) can either directly
perform enzyme catalysis (e.g. acid/base chemistry if it is a histidine) or induce protein conformational changes that a¡ect catalysis at
sites distant to the haem. Similarly, forcing a trans ligand to bond to a 5-coordinate nitrosyl complex weakens the Fe^NO bond and
may induce NO dissociation.
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Fe2, a linear geometry of the Fe3^NO bond is
favoured [45]. Optical and EPR spectroscopy [45]
suggest that the unpaired electron originating from
NO transfers to the iron atom, making the spin-
coupled ferrous^nitrosonium formulation more accu-
rate in this case (Fe2^NO). This is consistent with
the linear Fe^N^O bond as this is the favoured ge-
ometry for NO ligation [12]. Table 2 illustrates the
kinetic and thermodynamic parameters for this reac-
tion. It can clearly be seen that NO binds less tightly
to ferric, as opposed to ferrous, iron. The NO on-
rate can approach 107 M31 s31 when the distal side
of the haem is free as in catalase, elephant myoglobin
(which lacks a distal histidine ligand) or the 5-coor-
dinate arti¢cial undecapeptide microperoxidase;
however, for all proteins (Table 2) and model haems
[27] the o¡ rate for the ferric^NO complex is much
faster (by between 104 and 108 times) than for the
respective ferrous^NO complex.
Table 2





Dissociation constant (M) Reference
Haemoglobin 4U103 1 2.5U1034 [41]
Haemoglobin K-chains 3.3U103 2.1 1.4U1034 [41]
Haemoglobin L-chains 1.3U104 3 2.3U1034 [41]
Myoglobin (sperm whale) 5.3U104 14 2.6U1034 [27,42,43]
Myoglobin (elephant) 2.2U107 40 1.8U1036 [41]
Microperoxidase 1.1U106 3.4 3.1U1036 [42]
Cytochrome c 1U103 0.03 3U1035 [27,43,44]
Catalase 2U106 1 5U1037 This paper (see text)
3U107 170 6U1036 [27]
For haemoglobin, myoglobin and microperoxidase, the dissociation constant has been determined as the ratio of the o¡ and on rates,
rather than being measured directly. For catalase and cytochrome c, direct measurements of the dissociation constant gave very close
agreement to that determined from the kinetic data.
Fig. 3. Structures of some important non-haem iron nitrosyl complexes. Iron^sulphur^dinitrosyl complexes are detectable in most
physiological circumstances where NO production is enhanced. Sodium nitroprusside is a NO donor used to induce hypotension clini-
cally. Diethyldithiocarbamate makes an iron complex that readily binds NO and has been used to trap NO in a number of animal
models of human diseases where NO overproduction is implicated (e.g. sepsis, hypoxia-ischaemia, transplant rejection).
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NO binding to ferric haem is also less reversible
than to ferrous haem and, in many cases, reductive
nitrosylation converts the ferric^NO complex to the
ferrous iron (cf. later). Even this reaction, however,
occurs slowly on the biological time scale (with a
half-life of 10 min at neutral pH for haemoglobin,
and longer for other proteins [43,45].
The only enzyme where it has been suggested
where NO may inhibit the ferric form is catalase
[8]. However, the apparent Ki (0.3 WM) measured
by enzyme inhibition seems too high for the reported
Kd (5 WM) measured spectroscopically [27]. This Kd
was measured in an unbu¡ered solution of ill-de¢ned
pH. We have re-measured the Kd at pH 7 (C. Cooper
and P. Nicholls unpublished observations) and found
a value of 0.5 WM (Table 2) consistent with a role for
NO binding to ferric haem in the observed inhibition
of catalase at this pH [8].
3. Chemical reactivity of NO with iron
3.1. NO and ferrous iron
Although reversible binding reactions predominate
(cf. earlier) some metabolism of Fe2^NO complexes
can occur. This is likely to be important with the
very stable haem^NO complexes (e.g. nitrosyl hae-
moglobin) as otherwise given the very slow o¡ rates,
there would be a signi¢cant accumulation of these
complexes in vivo. For example the dissociation
rate of the Hb2^NO complex is approximately
1U1035 s31 ; yet the half-life for the Hb2^NO com-
plex in vivo following removal of an NO stimulus is
15 min [46], suggesting a much faster dissociation
rate. This anomaly can be explained by the reaction
of nitrosyl haemoglobin (or myoglobin) with oxygen
which generates methaemoglobin and nitrate. Di¡er-
ent mechanisms have been proposed for this reac-
tion. However, given that the Fe2^NO dissociation
rate (1U1035 s31) is slower than observed rates of
Fe2^NO conversion to metmyoglobin and nitrite
(which can be as high as 1U1033 s31 at saturating
oxygen tension), it seems likely that a direct reaction
occurs in the haem pocket between oxygen and the
nitrosyl complex, perhaps generating an intermediate
haem^peroxynitrite adduct [47].
Fe2 ÿNOO2 ! Fe3 ÿONOO3 ! Fe3 NO33
3
Clearly, this mechanism opens the possibility of
some peroxynitrite formation if dissociation can oc-
cur prior to the coordinate sphere rearrangement
that forms nitrate.
3.2. NO and ferric iron
Some Fe3^NO complexes are quite stable (e.g.
catalase, horse radish peroxidase, cytochrome c per-
oxidase), whereas others (e.g. metmyoglobin, met-
haemoglobin, cytochrome c) react further [43,45,
48]. In the case of haemoglobin and myoglobin, an
autoreduction process in the presence of NO leads to
the Fe2^NO complex. The ferric^NO autoreduction
reaction is best characterised by a water (Eq. 5) or
hydroxide (Eq. 6) attack on the ferrous nitrosonium
ion complex formed following NO addition to the
ferric iron (Eq. 4)
NO Fe3HFe3 ÿNO Fe2 ÿNO 4
followed by:
Fe2 ÿNO OH3 ! Fe2 NO32 H 5
or:
Fe2 ÿNO H2O! Fe2 NO32  2H 6
In the case of autoreduction of the ferricyto-
chrome c^NO complex, ferrocytochrome c is the nor-
mal product as the ferrocytochrome c nitrosyl com-
plex forms so slowly at neutral pH [43,44,49].
However, for myoglobin and haemoglobin the fer-
rous iron further reacts with the NO in the solution
to form the ferrous nitrosyl complex:
Fe2 NO! Fe2 ÿNO 7
An alternative mechanism has been suggested in-
volving binding of a second molecule of NO prior to
the hydrolysis reaction [45]. However, at least in the
case of cytochrome c, this mechanism is not valid
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because, as described above, ferrocytochrome c, not
the ferrous nitrosyl complex, is the end-product of
the interaction of ferricytochrome c with NO
[43,44,49].
These reactions are relatively slow [43]. The rate
constant for Eq. 5 is 3.2U103 M31 s31 for methae-
moglobin, 1.5U103 M31 s31 for ferricytochrome c,
and 1.5U102 M31 s31 for metmyoglobin. Therefore,
although at pH 10 the half-life of a 0.1 WM methae-
moglobin^NO solution would be 2 s, at pH 8, it
would be 200 s. Eq. 6 appears to occur at a signi¢-
cant rate only in the methaemoglobin^NO case
where a rate constant of 1.1U1033 s31 has been
measured [43]. Therefore, at pH 7 and below, met-
haemoglobin^NO still decays with a half-life of ap-
proximately 500 s, whilst metmyoglobin^NO and fer-
ricytochrome c^NO are signi¢cantly more stable.
Although of chemical interest, the biological rele-
vance of these slow reactions is hard to discern. The
end-products are non-toxic and the relative slow for-
mation rates and a⁄nities (Table 1) of the ferric
nitrosyl complexes will ensure that these pathways
are only of minor importance in vivo.
3.3. NO and ferryl iron
Ferryl iron (Fe4NO23)2 is a strong oxidising
agent essential for many enzyme-catalysed reactions
(e.g. catalases, peroxidases) and may also play a role
in pathophysiological processes [50]. There have been
no studies demonstrating that NO binds to this spe-
cies, but reduction of ferryl by NO has been demon-
strated in a number of cases [51,52]. The reaction is
slow (minutes) compared to more readily available
biological antioxidants (e.g. ascorbate), even in the
presence of 1.6 mM NO [52]. Although a much faster
reduction is seen when NO is added to ferryl cyto-
chrome oxidase [53], we attribute this to side-reac-
tions following rapid NO binding and metabolism at
the copper in the enzyme’s haem:copper binuclear
Fig. 4. An overview of haem iron:NO interreactions and their importance. An overview of the interactions of nitric oxide and haem
iron described in the text, indicating the most biologically relevant reactions.
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centre. The inhibition of catalase discussed previ-
ously also seems readily explainable via the reaction
of NO with ferric iron, and not the ferryl intermedi-
ate. Therefore as the interaction of NO with ferryl
intermediates is slow even at unphysiologically high
NO concentrations this reaction appears unlikely to
be of biological relevance.
3.4. NO and iron^oxy complexes
NO rapidly reacts with the oxy-complex of haem
proteins (e.g. oxygenated haemoglobin or myoglo-
bin). The product is nitrate and the ferric (met) pro-
tein [54]. The rate has been determined to be 4U107
M31 s31 [55], similar to NO binding to ferrous haem
enzymes (Table 1). The iron^oxygen interaction in
oxyhaemoglobin has both covalent (HbII^O2) and
ionic characteristics (Hb3^Oc32 ). The reaction mech-
anism with NO is best understood assuming the ionic
character of this complex (i.e. ferric:superoxide). As
with the reaction of Hb2^NO with O2 (cf. earlier) it
has been suggested that a transient haem-bound per-
oxynitrite intermediate is formed [55], in this case,
via the interaction of NO with the bound superoxide.
Fe3 ÿOc32 NO! Fe3 ÿONOO3 ! Fe3 NO33
8
The speed of this reaction and the large concen-
tration of oxyhaemoglobin in the blood suggests that
this is the major reason for the rapid removal of NO
in the vasculature.
3.5. NO reactivity with iron proteins is not always due
to direct action at the iron site: a cautionary note
One must be careful not to underestimate the pro-
tein moiety when studying the reactions of NO with
iron proteins. In particular, sulphydryl groups and
free radical intermediates are both likely to be targets
for NO reactivity and, unless careful spectroscopy is
undertaken, reactions outside the iron centre may be
falsely attributed to NO binding to iron. Examples of
iron proteins where this occurs include haemoglobin,
where the formation of cysteine S^NO complexes has
been shown to modulate haemoglobin reactivity with
oxygen [56]. Recent data suggest that mitochondrial
complex I (NADH dehydrogenase) is reversibly in-
hibited by NO, not at its myriad iron centres, but
instead via R^SNO formation at a sulphydryl site [9].
In the case of the non-haem iron enzyme ribonucleo-
tide reductase NO binds both to 3SH residues [57]
and to a tyrosine radical essential for enzyme activity
[14,57^59] and disentangling inhibitory e¡ects at
these sites from possible direct e¡ects on the dinu-
clear iron centre is therefore not trivial.
4. Reactions of NO-related compounds with iron
4.1. Nitroxyl anion
The putative role of nitroxyl anion in biology is
controversial [60^62]. However, it has been suggested
that it is the initial product of the enzyme nitric oxide
synthase [63] and that it can also be formed when
NO reacts with ferrocytochrome c [44]. The reactions
of NO3 with iron are relatively straightforward. It
forms a ferrous nitrosyl complex following addition
to ferric haem proteins. The rate constant for the
reaction of NO3 with ferric haem proteins is un-
known, but product analysis shows that it is compet-
itive with the rapid decomposition rate of NO3 to
N2O [64] or its reaction with oxygen to form perox-
ynitrite [44,65]. Two mechanisms are possible de-
pending on whether outer sphere electron transfer
is involved or not:
Fe3 NO3 ! Fe2 NO! Fe2 ÿNO 9
or:
Fe3 NO3 ! Fe3 ÿNO3 ! Fe2 ÿNO 10
In the presence of a large excess of oxygen, the
nitroxyl anion is still able to form a myoglobin nitro-
syl complex [44]. Given that the rate constants for
oxygen and NO binding to Fe2 are similar, and that
the oxy-complex would then react with free NO to
form ferric(met) myoglobin, these results suggest that
free NO in solution would not be able to form the
nitrosyl complex under these conditions; this e¡ec-
tively rules out Eq. 9 and favours Eq. 10, [64]. How-
ever, in the case of ferricytochrome c [54], Eq. 9 must
be favoured as the initial product is ferrocytochrome
c (at pH 7 the formation of the ferrous nitrosyl com-
plex is so slow that the intermediate ferrocytochrome
c is clearly seen).
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Nitroxyl anion also reacts rapidly with oxy- and
deoxy-haemoglobin and myoglobin. In the case of
the deoxy species, both Fe3 and Fe2^NO species
can be formed, whereas the oxy form results in stoi-
chiometric conversion to the ferric(met) form. The
overall stoichiometry is outlined in Eqs. 11 and 12,
but the detailed reaction mechanisms are controver-
sial [54,66]; in the case of deoxyhaemoglobin, NO3
has been suggested to be a catalyst for a complicated
set of reactions between nitrite and deoxyhaemoglo-
bin [54].
2Fe2 ÿO2 NO3 ! 2Fe3 NO33 O232 11
2Fe2 H NO23ÿ!NO
3
Fe3  Fe2 ÿNOOH3
12
4.2. Peroxynitrite
It has been suggested [11,67] that peroxynitrite can
generate a reactive nitronium ion (NO2 ) intermedi-
ate via binding to ferric iron (e.g. in iron^EDTA).
This can have pathological implications as it can
proceed to oxidise a variety of phenolic compounds,
including tyrosine:
Fe3 ONOO3 ! Fe2 ÿON3 ÿNON2 13
followed by:
Fe2 ÿON3 ÿNON2  phenol
! NO2 ÿ phenolH  Fe2 ÿO3 14
followed by:
Fe2 ÿO3  2H ! Fe3 H2O 15
These reactions require that the phenolic com-
pound can react with the nitronium ion intermediate,
and may therefore be more likely to occur in low-
molecular-weight iron complexes than in metallopro-
teins (where there may be restricted access for such
molecules). Furthermore many ferric haem proteins
can stabilise ferryl intermediates and this provides an
alternative pathway for the species generated above
to dissociate:
Fe2 ÿON3 ÿNON2 ! Fe4NO23 NO2 16
Depending on whether NO32 or NO2 is the leaving
group, the overall e¡ect is that peroxynitrite can act
as a one-electron or two-electron oxidant for ferric
haem proteins. It can thus convert ferric iron to the
ferryl intermediates with or without formation of a
cation radical [68].
Fe3 ONOO3 R! Fe4NO232 Rc NO32
17
Fe3 ONOO3 ! Fe4NO232 NO2 18
One electron oxidation (Eq. 18) seems favoured in
the case of lactoperoxidase and myeloperoxidase,
whereas two-electron oxidation (Eq. 17) occurs for
horseradish peroxidase [68]. Clearly these reac-
tions have possible pathophysiological signi¢cance
as ferryl iron and the associated free radical species
(e.g. ferryl haemoglobin and ferryl myoglobin) are
associated with oxidative stress damage to cells
[69]. They also shed some doubt on the proposed
ferric peroxynitrite intermediate in the reactions of
oxyhaemoglobin with NO and nitrosyl haemoglobin
with O2 (Eqs. 3 and 8); according to the above
mechanisms, one would expect this intermediate to
be converted into ferryl haemoglobin and nitrite, not
methaemoglobin and nitrate.
Peroxynitrite reactions with ferrous haem proteins
are less well-characterised. We have recently demon-
strated that mitochondrial cytochrome oxidase catal-
yses the formation of nitric oxide from peroxynitrite
[70]. This leads to reversible enzyme inhibition by the
nitric oxide produced. However, we [70] and others
[71] have demonstrated that at high concentrations
of peroxynitrite (s 100 WM), cytochrome oxidase is
irreversibly denatured; NO formation may therefore
play a role in protecting cytochrome oxidase and
other mitochondrial proteins from peroxynitrite-in-
duced damage. The proposed mechanism is:
Fe2  2H ONOO3 ! Fe3 NOH2O2
19
Peroxynitrite can oxidise oxyhaemoglobin to meth-
aemoglobin (forward rate 2.5U104 M31 s31) and
reduce ferryl haemoglobin to methaemoglobin,
although the reaction mechanisms are not well-char-
acterised [72].
High concentrations of peroxynitrite can also
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damage iron prosthetic groups in enzymes e.g. iron^
sulphur clusters in aconitase [73,74] and haem groups
in cytochrome oxidase [70]. These are not necessarily
reactions that occur at the iron atom itself and may
result from reactions with sulphydryl groups or por-
phyrins.
5. NO and iron in biological systems: which chemical
reactivity is relevant to which biology?
5.1. Non-protein bound iron
Table 1 shows that non-protein bound iron can
react with nitric oxide. However, it is unclear
whether these reactions occur in vivo, or if they
are, how important they are. Relevant studies are
hard to do, given the unclear chemical nature of
low-molecular-weight iron pools in cells [75,76].
One reaction that de¢nitely does occur in vivo is
the formation of iron^sulphur^nitrosyl complexes.
Of these, one particular species, the dinitrosylirondi-
thiol complex (DNIC) [77,78] is readily detectable by
EPR spectroscopy (with a g-value in the region of
2.03^2.04) and has therefore been much studied (Fig.
3). This species has been detected in a wide variety of
conditions from cancerous tissue [79] to the substan-
tia nigra of Parkinson’s disease brain tissue [80]. It is
associated with excess NO production in a number of
systems including macrophages, tumours, spinal
cords, endothelial cells, pancreatic islets and hepato-
cytes (for extensive reviews of the presence and im-
portance of this signal see [17,21,81,82]). A g = 2.04
signal is almost invariably observed following pro-
longed incubation of any biological material with
NO, or NO donors. It has been suggested that
DNIC is diagnostic for damage to mitochondrial
iron^sulphur enzymes [81]. However, quantitative
studies of the amount of DNIC formed compared
to the amount of iron^sulphur enzyme damage sug-
gest that in many cases, the majority of the iron and
sulphur in DNIC does not come primarily from pre-
formed iron^sulphur centres in proteins [83,84].
DNIC can be readily made in vitro by the addition
of ferrous iron, cysteine and NO [85]. It therefore
seems likely that the low-molecular-weight iron
pool is the main, though not exclusive, source of
DNIC iron in vivo. It is not clear whether this
reaction perturbs iron metabolism detrimentally;
although DNIC formation may have long-term con-
sequences in vivo, short-term function (e.g. of mito-
chondrial electron transfer) seems una¡ected by large
increases in DNIC concentration [84].
Whilst the biological relevance of the reactions of
non-protein bound iron with NO is unclear, the bio-
medical and spectroscopic implications of this chem-
istry have been readily exploited (Fig. 3). For exam-
ple, sodium nitroprusside is a NO (or more precisely
NO) donor used to lower blood pressure; NO che-
lators used to quantify NO in vivo frequently contain
iron, the best known of which is the iron complex of
diethyldithiocarbamate [86]. Recently NO imaging
has been made possible by the use of narrow lines
of the NO^Fe complex of N-(dithiocarboxy)sarcosine
[87].
5.2. Haem proteins
The reactions of NO with haem enzymes are of
obvious biological signi¢cance. The mammalian
NO synthase [88] and the bacterial cd1 nitrite reduc-
tase [89] both synthesise NO and both utilise haem
co-factors. The best-characterised mammalian (gua-
nylate cyclase [3]) and bacterial (nitric oxide reduc-
tase [90]) target enzymes for NO action, both contain
haem iron. The similarity of NO with oxygen sug-
gests that any haem enzyme that reacts with oxygen
will be a potential target for NO inhibition (Table 1).
Thus, whilst 6-coordinate low spin haem proteins
(e.g. the mitochondrial cytochromes b and c) in gen-
eral react poorly with oxygen (and therefore CO and
NO), any high spin 5-coordinate haem enzymes that
can bind and/or activate O2 will also bind NO. Such
enzymes include cytochrome oxidase, the cytochrome
P-450 superfamily and haemoglobin. Given the po-
tential strength of NO binding to ferrous haem (and
the consequent slow o¡ rates (Table 1)), it is di⁄cult
to see how proteins with high spin ferrous haem can
avoid being inhibited by NO. As an enzyme that
expects to be in the presence of NO rather fre-
quently, nitric oxide synthase, has not been able to
completely avoid inhibition by NO [91], it is quite
likely that all enzymes with high spin ferrous haem
intermediates are inhibited by NO to some extent. It
is also likely that this inhibition will be competitive
with oxygen and CO as these bind to the same redox
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state ^ the biological question to answer is whether
the nM levels of NO usually present are below or
above the relevant Ki. In the case of cytochrome
oxidase, mechanisms seem to exist to make NO an
even stronger inhibitor (probably due to the binu-
clear haem^copper nature of the oxygen reduction
site), and it seems very likely that the inhibition
here is signi¢cant under pathophysiological, and
maybe physiological, conditions [4^6].
However, despite these ¢ndings, iron protein enzy-
mology does not permanently grind to a halt for
hours following the addition of excess nitric oxide.
The solution to the problem of over tight binding of
NO to ferrous haem enzymes seems to have been
solved by biology via a combination of either pre-
venting bond formation and/or increasing the rate of
NO dissociation.
5.2.1. Prevention of Fe2+^NO formation
In the blood cell, NO rapidly reacts with oxyhae-
moglobin to form methaemoglobin and nitrate. It is
possible that other scavenging enzymes/proteins may
prevent NO reaching especially sensitive enzymes in
other parts of the body. Some haem enzymes have to
react with NO as product or substrate (e.g. bacterial
nitrite reductase and nitric oxide reductase). In this
case, a complex reaction mechanism has been postu-
lated to prevent the formation of a ferrous^nitrosyl
bond during the reaction cycle [90].
5.2.2. Increase in the rate of Fe2+^NO dissociation
The problem of the potential for NO to form
strong ferrous nitrosyl bonds in proteins has been
overcome in two di¡erent ways. Firstly the protein
can be modi¢ed to increase this dissociation rate as
appears to be the case in both guanylate cyclase and
cytochrome oxidase; here the faster than expected
dissociation rates for NO allowing the enzymes to
rapidly become de-inhibited (over seconds, not mi-
nutes) when the NO stimulus is removed. Alterna-
tively the Fe2^NO complex can be ‘metabolised’.
Nitrosyl haemoglobin is stable for days anaerobi-
cally. In the presence of oxygen it is converted to
nitrate and methaemoglobin (cf. earlier). The latter
is then rapidly reduced to deoxyhaemoglobin by
methaemoglobin reductase. Although this whole
process still takes many minutes, the NO scavenging
by oxyhaemoglobin described above means that the
Hb^NO level never reaches a large fraction of the
total Hb in the blood cell in the ¢rst place. There-
fore, this rather leisurely pace of recycling of the
active protein is su⁄cient to ensure that the very
low Hb^NO dissociation constant (0.03 nM) does
not result in all the blood haemoglobin ending in
this inhibitory complex. In fact, even following en-
dotoxaemia in the rat (the biological situation where
probably NO production is at its maximum), at
most, only 2% of the total haemoglobin concentra-
tion is trapped as Hb^NO [92].
Peroxidases and catalases generally do not form
ferrous iron complexes in their reaction cycle; the
weaker binding of NO to the ferric (Table 2) and
ferryl states therefore makes these enzymes more re-
sistant to NO inhibition (although catalase appears
to be an exception here with strong NO binding due
to the electron donating properties of the proximal
tyrosinate ligand increasing the electronegativity of
the ferric state [8]).
A summary of the interactions of haem iron and
nitric oxide is illustrated in Fig. 4.
5.3. Non-haem iron proteins
The signi¢cance of the reactions of NO with non-
haem iron enzymes is less clear. Part of the problem,
when comparing haem with non-haem iron enzymes,
is that the lack of clear optical spectroscopic signals
in the latter case means that far less work has been
performed. However, EPR spectroscopy shows that
ferrous iron in these enzymes can form well-charac-
terised NO complexes (for a discussion of the iron
spin states that result in EPR-detectable signals see
[39]).
Again, enzymes that react with oxygen (e.g. mono-
oxygenases and dioxygenases) have the potential to
make nitrosyl complexes [16,93^95]. Relevant inhib-
ition studies have only been carried out in a few
cases. In the case of lipoxygenase, it has been deter-
mined that the levels of NO required for inhibition
are higher than those normally found even under
pathophysiological conditions [96]. This is in line
with the fact that non-haem iron enzymes in general
bind ligands at the iron site less tightly than haem
proteins. In the case of NO, the ferrous iron fre-
quently remains high spin (S = 2) resulting in an
EPR signal due to an S = 3/2 spin system (when
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spin coupled to the S = 1/2 NO molecule). In haem
enzymes, the iron is low spin ferrous, S = 0, and the
resulting EPR signal for the NO complex is, there-
fore, S = 1/2.
As well as iron enzymes, iron storage proteins can
react with NO. Ferritin has a complex series of in-
teractions with NO that include signals from S = 1/2
and S = 3/2 spin states [97,98]. It is possible that these
interactions are responsible for the ability of NO to
release iron from ferritin stores [99]. Metallothio-
neins are small, sulphur-rich metal-binding polypep-
tides produced in response to a variety of physiolog-
ical and environmental stresses. In the presence of
iron and NO, both apo-metallothionein and Zn-met-
allothionein form EPR spectra similar to DNIC
[100]. Again whether this is due to sulphur residues
being removed from the metallothionein, or a genu-
ine interaction of iron, cysteine and NO in an un-
damaged metallothionein molecule is unclear.
The caveats mentioned earlier about demonstrat-
ing that NO is de¢nitely acting at the iron site are
especially true for some of the non-haem iron en-
zymes. NO can directly scavenge free radicals. In
the case of lipoxygenase, the products of catalysis
are free radicals and in ribonucleotide reductase, a
protein-bound tyrosine radical is required for enzyme
activity. NO interactions and inhibition may, there-
fore [14], arise from radical coupling reactions (Eq.
20) rather than direct binding to iron and careful




Following the previous suggestions that NO will
react at iron sites free to bind oxygen, most iron^
sulphur clusters are unlikely targets for NO inhibi-
tion/damage. The electron-transferring iron^sulphur
centres in the mitochondrial electron transfer chain
are likely to be buried in the protein and, therefore,
relatively inaccessible to oxygen or NO. Isolated
iron^sulphur clusters, free of protein ligation, are
inherently sensitive to oxidation by oxygen. This sen-
sitivity is maintained in some protein-bound clusters.
For example, if oxygen is present during the puri¢-
cation of iron^sulphur enzymes from anaerobic bac-
teria, the clusters are generally irreversibly destroyed
[101,102]. As these clusters do not need to bind exog-
enous ligands for their biological function, it is likely
that in aerobic organisms, protective mechanisms to
prevent oxygen damage will also prevent NO dam-
age. In this context, it is perhaps not surprising that
the best characterised direct inhibition of iron^sul-
phur enzymes by NO is in enzymes from anaerobic
bacteria [103^105]. It seems that insensitivity to NO
and O2 damage has co-evolved in iron^sulphur pro-
teins.
However, whilst pre-formed electron transferring
iron^sulphur proteins are, in general, insensitive to
NO, it is likely that cluster formation requires low-
molecular-weight iron and sulphur compounds that
will be sensitive to the presence of NO in the cell.
Thus, NO could indirectly inhibit electron transfer
reactions by preventing the formation of new iron^
sulphur clusters with the result that function dropped
o¡ with the turnover of old proteins in the cell. It has
been suggested that this is the reason for the ob-
served toxicity of nitrite used in food preservation
towards Clostridial species [101].
The above arguments do not hold for those rela-
tively recently discovered iron^sulphur enzymes with
non-redox roles [106]. Here it is frequently necessary
for low-molecular-weight compounds (e.g. citrate) to
interact with the cluster and it is harder conceptually
to see how access to NO could be prevented. These
are generally 4Fe^4S clusters. However, only three of
the iron atoms have cysteine coordination; the sub-
strate reacts at the non-cysteine coordinated iron
(Fea). Most notable of these are mitochondrial and
cytoplasmic aconitase [107].
The nature of the NO interaction with aconitase is
controversial, with some groups suggesting that per-
oxynitrite is the reactive species [73,74], whereas
others have suggested that NO itself is su⁄cient
[108^110]. It is clear that peroxynitrite can rapidly
and irreversibly inhibit both mitochondrial and cyto-
plasmic aconitase activity [73,74]. Oxidation of the
active [4Fe^4S]2 cluster results in loss of the non-
cysteine coordinated Fea centre, with subsequent for-
mation of the inactive [3Fe^4S] cluster [107]. Intri-
guingly, substrate binding seems to prevent this dam-
age [109], suggesting that peroxynitrite cannot access
the iron cluster in the presence of citrate in the active
site.
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High levels (100 WM) of NO can also inhibit aco-
nitase activity [74]. What is less clear is what occurs
at physiological (nM) or pathophysiological (low
WM) concentrations of NO. A recent study [109]
demonstrated speci¢c NO inactivation of aconitase
by attack at the non-cysteine coordinated iron site
(with eventual formation of protein-bound iron^sul-
phur dinitrosyl g = 2.04 EPR signals). In contrast to
the situation with peroxynitrite, substrate binding did
not prevent this inhibition. However, this spectros-
copic study required high concentrations of the pro-
tein (s 50 WM) and consequently high NO concen-
trations were employed (100 WM ‘authentic’ NO or
the equivalent from slow release NO donors). Even
under these conditions, the t1=2 for aconitase inhib-
ition was as high as 20 min. However, intriguingly, it
has been shown that NO can be a more e¡ective
aconitase inhibitor at lower pH or when the enzyme
was actively turning over [110]. In agreement with
previous studies [73,74], no inhibition of mitochon-
drial aconitase was observed at pH 7.5 by NO. How-
ever, a slow inhibition (t1=2 = 1 h) was observed at
pH 6.5 for the enzyme at rest. This raises the possi-
bility that during hypoxia or ischaemia, when NO
levels can rise in tissue [111] and the pH drops, aco-
nitase may become a more sensitive target for NO-
mediated damage. Perhaps of greater signi¢cance at
more physiological pH values inhibition could be
observed, but only if the enzyme was actively turning
over; this suggests that a turnover intermediate may
be susceptible to NO inhibition. The NO concentra-
tion was not directly measured in the solution, but
assuming perfect equilibration with the gas phase,
would have been in the high nM to low WM range
and, therefore, of pathophysiological, but not neces-
sarily physiological, relevance.
It has recently been demonstrated that iron metab-
olism is regulated by cytoplasmic aconitase. Cyto-
plasmic aconitase is identical [112^114] to the iron
regulatory element protein (IRP). This protein can
bind to the iron regulatory element (IRE) sequences
in the mRNA for ferritin (iron-storage protein), the
transferrin receptor (cellular iron import protein) and
erythroid 5-aminolevulinate synthase (an enzyme
that catalyses haem biosynthesis) [115]. IRP binding
represses the translation of mRNA for ferritin and
erythroid 5-aminolevulinate synthase, but protects
the mRNA for the transferrin receptor from degra-
dation. When the cells are starved of iron, IRE is
activated, binds to the mRNAs described above
and the consequent post-transcriptional gene regula-
tion assists the cell in accumulating iron, whilst pre-
venting what little iron is present being diverted into
storage or haem biosynthesis.
Intriguingly, the activation of IRP is triggered by
events at the iron^sulphur cluster. The 4Fe^4S clus-
ter has aconitase activity, but does not bind to the
IRE. The apoprotein has no aconitase activity, but
does bind to the IRE. The 3Fe^4S cluster has neither
aconitase activity nor does it bind to the IRE [116].
It has recently been suggested that NO may play a
role in activating the IRP [117]. What is the evidence
for this? It is clear that when high (WM) levels of NO
are produced in activated rodent macrophages and
cell lines, the g = 2.04 DNIC EPR signal can be de-
tected simultaneously with inhibition of cytoplasmic
aconitase activity and activation of the IRP
[10,118,119]. Addition of 50 WM ‘authentic’ NO to
pure IRP yielded a similar e¡ect i.e. loss of both its
aconitase activity and activation of its binding to the
IRE [118]. It is not clear whether the cellular e¡ects
are due to the direct action of NO on the iron^sul-
phur cluster, given the relatively high levels of NO
required to remove the 4Fe^4S cluster [109] and ac-
tivate IRE binding in the pure IRP [109]. The situa-
tion may be even more problematic in mammalian
systems where less NO is generally produced than in
the rodent cells and rodent-derived cell lines that
have been primarily studied so far. Recent ¢ndings
have demonstrated that peroxynitrite can activate
IRP binding to IRE in vitro [120]. It is therefore
possible that in vivo the iron^sulphur cluster oxida-
tion and removal is catalysed by peroxynitrite, rather
than NO directly. However, given the ¢nding de-
scribed above that the enzyme in turnover is more
susceptible to NO inhibition [110], it may be that the
in vitro studies have not, as yet, been carried out
under the correct conditions to measure an e¡ect at
lower, more physiological, NO concentrations.
To summarise, when excess NO (WM) is produced
there is a slow inhibition of mitochondrial and cyto-
plasmic aconitase activity. Mitochondrial respiration
is, therefore, inhibited and the IRP activated. It is
possible, but not yet proven, that this is solely due
to NO binding at the Fea centre. The sensitive of the
iron^sulphur cluster to peroxynitrite oxidation means
BBABIO 44734 23-4-99
C.E. Cooper / Biochimica et Biophysica Acta 1411 (1999) 290^309 303
that peroxynitrite cannot be ruled out as a mediator
of the NO modulation of aconitase activity and IRE
binding.
5.5. NO, iron proteins and mitochondrial respiration:
what is the target?
There is confusion in the literature about the
mechanism by which NO inhibits mitochondrial res-
piration (see also the review by Brown in this issue
[121]). The initial ¢ndings suggested that NO,
whether added exogenously or via co-culture with
cells expressing NO synthase activity, damaged mito-
chondrial iron^sulphur enzymes and hence inhibited
mitochondrial respiration [122^125]. The evidence
for this was two-fold: ¢rstly, that the isolated iron^
sulphur enzyme activity (especially aconitase) was
inhibited; and secondly, that g = 2.04 EPR signals
from DNIC were formed in the target cells. The lat-
ter was assumed to occur from damage to mitochon-
drial iron^sulphur centres, e.g. aconitase. We, and
others, have countered both of these suggestions
with the demonstration that the initial target for
NO is mitochondrial cytochrome oxidase [5,7,126^
128] and that g = 2.04 signals alone do not necessarily
correlate with decreases in mitochondrial respiration
rate and damage to iron^sulphur enzymes [84]. To
add to the confusion, there has been a recent report
that the mitochondrial bc1 complex (complex III) is
also a target or NO inhibition [129] and that NO can
inhibit NADH dehydrogenase (mitochondrial com-
plex I) by reversibly binding to thiols [9]. Inhibition
in the latter case is reversed by glutathione, but be-
comes signi¢cant when mitochondrial glutathione
levels decline.
As with many studies with NO, there is some truth
in all these assertions, depending on the time scale
observed and the cellular NO and O2 concentrations.
If NO is added at nanomolar concentrations to aero-
bic mitochondria or cells it will undoubtedly inhibit
mitochondrial cytochrome oxidase ¢rst. The clearest
evidence is that the inhibition of cellular respiration
is rapid (on a seconds time scale), completely rever-
sible and oxygen concentration dependent [126]. All
these properties are identical with the interaction of
NO with puri¢ed cytochrome oxidase [126,130]. Fur-
thermore, optical spectra demonstrate that cyto-
chrome oxidase haem a reduction increases following
NO addition to isolated mitochondria [7] and cells
[126] ^ this is only possible if electron transfer is
blocked between haem a and oxygen i.e. at the cyto-
chrome oxidase binuclear centre. Inhibition at aconi-
tase or mitochondrial complexes, I, II or III would
all result in an oxidation of haem a.
However, subsequent to the rapid reversible inhib-
ition of cytochrome oxidase, the situation becomes
more complex. Long-term damage to mitochondrial
respiration may occur via a variety of subsequent
pathways. Peroxynitrite levels rise as superoxide lev-
els are increased when the mitochondrial electron
transfer chain is inhibited by NO [131]. Peroxynitrite
can irreversibly inhibit mitochondrial complexes I
[132], II [71,132] III [71,132], cytochrome oxidase
[70,71] and aconitase [73,74]. Persistent longer-term
(minutes to hours) incubation with NO itself will
lead to a gradual inhibition of mitochondrial com-
plex I, when mitochondrial glutathione levels can no
longer protect this enzyme [9]. A slow inhibition of
aconitase (over minutes to hours) may also occur
especially at higher (WM) NO concentrations [108^
110]. Over a similar time period, EPR signals will
be seen from DNIC at g = 2.04 [10,123,125]. Some
of these may be due to NO bound to aconitase
[109], although it will be di⁄cult to distinguish this
fraction from other non-protein-bound low-molecu-
lar-weight DNIC [83]. As there are a multitude of
irreversible targets for NO and peroxynitrite in mi-
tochondria, disentangling the speci¢c relevant inter-
actions is di⁄cult. Furthermore, peroxynitrite can
stimulate mitochondrial respiration by increasing
the mitochondrial proton leak rate, either directly
by damaging lipids [133] or indirectly by opening
the mitochondrial permeability transition pore
[134]. It is perhaps not surprising that the literature
in this area can appear confusing at times!
To summarise, in the presence of nanomolar con-
centrations of NO, mitochondrial cytochrome oxi-
dase is inhibited reversibly. Due to the low Ki, this
e¡ect will predominate whilst NO is present in the
solution. Upon the removal of NO, other less rever-
sible e¡ects can manifest themselves. Given that dif-
ferent enzymes exert di¡erent degrees of control over
the rate of mitochondrial respiration [135,136], in
order to determine the relevance of any irreversible
damage, it is not su⁄cient to measure decreases in
the isolated enzyme activity alone. Instead, a careful
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study varying the substrates for mitochondrial respi-
ration and using speci¢c inhibitors of key steps in
both glycolysis, oxidative phosphorylation and ATP
utilisation is required to determine the relevant site
of inhibition of the cellular respiration rate. It is, of
course, possible that inhibition of several pathways
may contribute to the overall depression of respira-
tion; the site of the irreversible damage may also
vary depending on a number of factors, e.g. cell
type, NO/peroxynitrite concentration, length of ex-
posure, mitochondrial glutathione stores. The recent
paper by Clementi et al. [9] demonstrating complex I
as the site of long-term damage following NO treat-
ment of J774 cells, is a good example of the ap-
proach necessary to elucidate which of the many
possible targets is relevant.
6. Conclusion
There is little doubt that the interaction of NO
with iron proteins is behind many, though by no
means all, of the important biological reactions of
NO. The range of possible protein targets is due to
the varied biological chemistry of NO which can re-
versibly bind to iron proteins, as well as having the
potential to act as an electron donor or an electron
acceptor. Many iron proteins have been suggested to
have their activity modulated by NO in vivo. With
the exception of guanlyate cyclase, the mechanism
and physiological relevance of these interactions is
still controversial.
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